TR-1 notification of major interest in shares

The full notification can be viewed here.

EKF Diagnostics

EKF Diagnostics Holdings plc is a manufacturer and distrbutor of IVD products. It has three core divisions: Point of Care including hemoglobin and HbA1c analyzers; Central Laboratory including the manufacture of enzymes and clinical chemistry; and Molecular Diagnostics which incorporates a unique DNA enrichment technology, PointMan, and a portfolio of molecular testing services.

News & events

EKF highlights ultra-sensitive cancer mutation detection kits at AACR

PointMan™ DNA-enrichment kits offer unrivalled cancer gene detection in whole blood.

Proposed acquisitions of Selah Genomics, Inc. and DiaSpect Medical AB

EKF Diagnostics announces that it has entered into a conditional agreement to acquire Selah Genomics, Inc. and DiaSpect Medical AB.a Swedish based manufacturer of point-of-care haemoglobin analysers.

PointMan at Tri-Con 2014

EKF Molecular Diagnostics is exhibiting its ground-breaking PointMan™ DNA-enrichment technology at Tri-Con 2014 in San Francisco, CA, Booth #417, 10-14th February.

PointMan™ successfully enriches low-level mutations in DNA extracted from blood

EKF Diagnostics Holdings plc announces a major breakthrough for its PointMan technology for potential use in future cancer testing and treatment.

EKF Diagnostics' Quo-Lab HbA1c analyzer secures IFCC Certification

Point-of-care analyzer meets all standards set by independent certifying bodies.